Santhera Announces First Trading Day of New Convertible Bonds on SIX Swiss Exchange
May 07, 2021 01:00 ET | Santhera Pharmaceuticals Holding AG
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Pratteln, Switzerland, May 7, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that...
Santhera gibt den ersten Handelstag der neuen Wandelanleihe an der SIX Swiss Exchange bekannt
May 07, 2021 01:00 ET | Santhera Pharmaceuticals Holding AG
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Pratteln, Schweiz, 7. Mai 2021 - Santhera Pharmaceuticals (SIX: SANN) gibt bekannt, dass...
Santhera Announces Settlement of Exchange Offer and Issuance of New Senior Unsecured Convertible Bonds due 2024
May 04, 2021 01:00 ET | Santhera Pharmaceuticals Holding AG
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Pratteln, Switzerland, May 4, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces the...
Santhera gibt den Vollzug des Umtauschangebots und die Ausgabe einer neuen vorrangigen, ungesicherten Wandelanleihe mit Fälligkeit 2024 bekannt
May 04, 2021 01:00 ET | Santhera Pharmaceuticals Holding AG
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Pratteln, Schweiz, 4. Mai 2021 – Santhera Pharmaceuticals (SIX: SANN) gibt den Vollzug des...
Santhera Announces Settlement of Convertible Bond Exchange Offer on May 4, 2021
May 03, 2021 01:00 ET | Santhera Pharmaceuticals Holding AG
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Pratteln, Switzerland, May 3, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that the...
Santhera gibt den Vollzug des Umtauschangebots für die Wandelanleihe per 4. Mai 2021 bekannt
May 03, 2021 01:00 ET | Santhera Pharmaceuticals Holding AG
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Pratteln, Schweiz, 3. Mai 2021 - Santhera Pharmaceuticals (SIX: SANN) gibt bekannt, dass das...
Santhera Completes Capital Increases for Financing Arrangements
April 30, 2021 11:45 ET | Santhera Pharmaceuticals Holding AG
Pratteln, Switzerland, April 30, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that it has issued 2,312,000 treasury shares. On April 30, 2021, Santhera completed the ordinary capital...
Santhera vollzieht Kapitalerhöhungen für Finanzierungen
April 30, 2021 11:45 ET | Santhera Pharmaceuticals Holding AG
Pratteln, Schweiz, 30. April 2021 – Santhera Pharmaceuticals (SIX: SANN) gibt die Ausgabe von 2'312'000 Vorratsaktien bekannt. Am 30. April 2021 vollzog Santhera die am 18. März 2021 beschlossene...
Santhera Reports 2020 Annual Results
April 29, 2021 01:00 ET | Santhera Pharmaceuticals Holding AG
A conference call will be held today at 14:00 CEST, 13:00 BST, 08:00 EDT. Details are at the end of this statement. Revenue from contracts with customers of CHF 15.0 millionOperating result of...
Santhera veröffentlicht Jahresabschluss 2020
April 29, 2021 01:00 ET | Santhera Pharmaceuticals Holding AG
Santhera wird heute um 14:00 MESZ, 13:00 GMT, 08:00 EDT eine Telefonkonferenz durchführen. Details dazu am Ende dieser Mitteilung. Umsätze aus Verträgen mit Kunden von CHF 15,0 MillionenOperatives...